Subscribe
william_potter
william_potter / iStockphoto.com
31 October 2018Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
Takeda makes fourth offer to buy Shire
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
EUIPO sides with Takeda in trademark appeal
28 November 2018   Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
Takeda makes fourth offer to buy Shire
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
EUIPO sides with Takeda in trademark appeal
28 November 2018   Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
Takeda makes fourth offer to buy Shire
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
EUIPO sides with Takeda in trademark appeal
28 November 2018   Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug